Key result
Cochrane Review protocol evaluates prophylactic corticosteroids in pediatric cardiopulmonary bypass surgery.
Why the study?
The benefits and harms of prophylactic corticosteroids in children undergoing cardiac surgery with cardiopulmonary bypass have not been fully assessed.
Do prophylactic corticosteroids improve outcomes in children between birth and 18 years of age undergoing cardiac surgery with cardiopulmonary bypass?
Do prophylactic corticosteroids improve outcomes in children between birth and 18 years of age undergoing cardiac surgery with cardiopulmonary bypass?
This is a protocol for a Cochrane Review to assess the benefits and harms of prophylactic corticosteroids in pediatric cardiac surgery with cardiopulmonary bypass.
Cochrane protocol underway for prophylactic corticosteroids in pediatric CPB; leaves open optimal perioperative strategy pending synthesis.
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of prophylactic corticosteroids in children between birth and 18 years of age undergoing cardiac surgery with cardiopulmonary bypass.
No takes yet. Share an insight, caveat, or question.
Gibbison et al. (2018) studied this question. Prophylactic corticosteroids are being evaluated for benefits and harms in children undergoing cardiopulmonary bypass surgery in a Cochrane Review protocol.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: